Acknowledgement for APICES collaboration in GREKO study published in «Clinical and Translational Oncology«

We want to share the acknowledgment that APICES has received in the recent publication titled “Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (Granulosa Et Ketoconazole) trial, GETHI 2011-03”. published in Clinical and Translational Oncology in which APICES has collaborated in project…

Clinical Operations in Oncology Trials Europe 2022

APICES is actively participating in the upcoming CLINICAL OPERATIONS IN ONCOLOGY TRIALS EUROPE 2022 congress in Zurich. In the following link you can access the agenda. Clinical Operations in Oncology Trials Europe 2022 On November 23rd, Ana Moreno, Director Global Clinical Operations at APICES, will give us her opinion regarding how to succeed in your…

Acknowledgement for APICES collaboration in study ABIDO published in » European Journal of Cancer»

This month, we want to share the acknowledgment that APICES has received in the recent publication titled “A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial”. published in…

Acknowledgement for APICES collaboration in DERMIA study published in «Supportive Care in Cancer»

This month, we want to share the acknowledgment that APICES has received in the recent publication titled “A phase 2 study for evaluating doxycycline 50 mg once daily and 100 mg once daily as preemptive treatment for skin toxicity in patients with metastatic colorectal cancer treated with an anti-EGFR and chemotherapy” published in Supportive Care in…

Acknowledgement for APICES collaboration in ABACUS trial published in «European Urology»

Once more time we are privileged to share the acknowledgment that APICES has received in the recent publication titled: “Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder”. This is an extra motivation for the whole APICES team. These achievements would not be possible without the involvement of every…

Acknowledgement for APICES collaboration in DART 01/05 study published in «The Lancet Oncology»

Once more time we are privileged to share the acknowledgment that APICES has received in the recent publication titled: “High-dose radiotherapy and risk-adapted androgen deprivation in localized prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial”. This is an extra motivation for the whole APICES team. These achievements would not be…